These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11170126)

  • 1. In vivo model mimicking natural history of dog prostate cancer using DPC-1, a new canine prostate carcinoma cell line.
    Anidjar M; Villette JM; Devauchelle P; Delisle F; Cotard JP; Billotey C; Cochand-Priollet B; Copin H; Barnoux M; Triballeau S; Rain JD; Fiet J; Teillac P; Berthon P; Cussenot O
    Prostate; 2001 Jan; 46(1):2-10. PubMed ID: 11170126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dog prostate cancer (DPC-1) model: a reliable tool for molecular imaging of prostate tumors and metastases.
    Chevalier S; Moffett S; Turcotte E; Luz M; Chauvette L; Derbekyan V; Scarlata E; Zouanat F; Aprikian AG; Anidjar M
    EJNMMI Res; 2015 Dec; 5(1):77. PubMed ID: 26714499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refining the orthotopic dog prostate cancer (DPC)-1 model to better bridge the gap between rodents and men.
    Anidjar M; Scarlata E; Cury FL; Rocha J; Hamel L; Luz M; Chevalier S
    Prostate; 2012 May; 72(7):752-61. PubMed ID: 21882212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.
    Smith-Jones PM; Vallabhajosula S; Navarro V; Bastidas D; Goldsmith SJ; Bander NH
    J Nucl Med; 2003 Apr; 44(4):610-7. PubMed ID: 12679407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental studies for immunoscintigraphy of adenocarcinoma of the prostate with 125I-labeled monoclonal antibody to gamma-seminoprotein].
    Fujino A; Suyama K; Shidara T; Ao T; Ishibashi A; Koshiba K
    Nihon Hinyokika Gakkai Zasshi; 1994 Feb; 85(2):271-80. PubMed ID: 8121109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen.
    Elsässer-Beile U; Reischl G; Wiehr S; Bühler P; Wolf P; Alt K; Shively J; Judenhofer MS; Machulla HJ; Pichler BJ
    J Nucl Med; 2009 Apr; 50(4):606-11. PubMed ID: 19289418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human GRPr-transfected Ace-1 canine prostate cancer model in mice.
    Ding H; Kothandaraman S; Gong L; Williams MM; Dirksen WP; Rosol TJ; Tweedle MF
    Prostate; 2016 Jun; 76(9):783-95. PubMed ID: 26940014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mouse model of human prostate cancer to study intraprostatic tumor growth and the development of lymph node metastases.
    Linxweiler J; Körbel C; Müller A; Hammer M; Veith C; Bohle RM; Stöckle M; Junker K; Menger MD; Saar M
    Prostate; 2018 Jun; 78(9):664-675. PubMed ID: 29572953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor effects and lack of side effects in mice of an immunotoxin directed against human and mouse prostate-specific membrane antigen.
    Huang X; Bennett M; Thorpe PE
    Prostate; 2004 Sep; 61(1):1-11. PubMed ID: 15287089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen.
    Li Y; Tian Z; Rizvi SM; Bander NH; Allen BJ
    Prostate Cancer Prostatic Dis; 2002; 5(1):36-46. PubMed ID: 15195129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orthotopic tumorgrafts in nude mice: A new method to study human prostate cancer.
    Saar M; Körbel C; Linxweiler J; Jung V; Kamradt J; Hasenfus A; Stöckle M; Unteregger G; Menger MD
    Prostate; 2015 Oct; 75(14):1526-37. PubMed ID: 26074274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic model for human prostate cancer using orthotopic implantation in nude mice.
    Stephenson RA; Dinney CP; Gohji K; Ordóñez NG; Killion JJ; Fidler IJ
    J Natl Cancer Inst; 1992 Jun; 84(12):951-7. PubMed ID: 1378502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Site-Specifically Conjugated Monomethyl Auristatin E- and Duocarmycin-Based Anti-PSMA Antibody-Drug Conjugates for Treatment of PSMA-Expressing Tumors.
    Lütje S; Gerrits D; Molkenboer-Kuenen JD; Herrmann K; Fracasso G; Colombatti M; Boerman OC; Heskamp S
    J Nucl Med; 2018 Mar; 59(3):494-501. PubMed ID: 29146698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of a human primary prostate carcinoma cell line, HH870.
    Selvan SR; Cornforth AN; Rao NP; Reid YA; Schiltz PM; Liao RP; Price DT; Heinemann FS; Dillman RO
    Prostate; 2005 Apr; 63(1):91-103. PubMed ID: 15468172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.
    Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
    J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth of a spontaneous canine prostatic adenocarcinoma in vivo and in vitro: isolation and characterization of a neoplastic prostatic epithelial cell line, CPA 1.
    Eaton CL; Pierrepoint CG
    Prostate; 1988; 12(2):129-43. PubMed ID: 3368402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.